Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Fampridine-SR
Fampridine-SR
FDA delays ruling on Acorda's MS drug until Jan. 22
Yahoo/AP
Thu, 10/22/09 - 09:14 am
Acorda Therapeutics
FDA
MS
multiple sclerosis
Fampridine-SR
Acorda’s MS Drug May Need More Study, U.S. FDA Says
Bloomberg
Fri, 10/9/09 - 09:30 am
Acorda Therapeutics
MS
multiple sclerosis
Fampridine-SR
Acorda Therapeutics cites additional positive safety data on multiple sclerosis drug
Yahoo/AP
Tue, 09/15/09 - 07:47 pm
Acorda Therapeutics
multiple sclerosis
MS
Fampridine-SR
Acorda confirms FDA panel review date for MS drug
Yahoo/AP
Tue, 08/25/09 - 12:22 pm
Acorda Therapeutics
MS
FDA
multiple sclerosis
Fampridine-SR
Biogen Buys Rights to Acorda’s MS Pill Outside U.S.
Bloomberg
Wed, 07/1/09 - 09:05 am
Biogen Idec
Acorda Therapeutics
Fampridine-SR
MS
We're Positive on Acorda
Yahoo/Zacks.com
Tue, 06/23/09 - 08:36 am
Acorda Therapeutics
Fampridine-SR
FDA Won't Review Acorda's MS Drug
TheStreet.com
Tue, 03/31/09 - 08:05 am
FDA
MS
multiple sclerosis
Acorda Therapeutics
Fampridine-SR
